Vaccines

What's Going On With Pfizer Shares Wednesday?
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Bird Flu Spreads To Cats, Possibly Horses As Officials Signal No Plans To Authorize Vaccination
Bird Flu Found In Raw Milk Leads To Recall In California

Vaccines Recent News

WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'
To fight the mpox outbreak in Africa, the World Health Organization calls for funding help for its six-month plan.
Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency
Bavarian Nordic submits data to European Medicines Agency seeking approval to extend Imvanex vaccine use to adolescents. New trials in younger children planned as global demand for smallpox and mpox vaccines rises.
WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak
A public health emergency for mpox in Africa saw vaccine stocks jump Wednesday. A look at the stocks and what's next for fighting the virus.
AstraZeneca's $578M Vaccine Plant In Doubt As UK Government Cuts Funding
AstraZeneca is raising concerns that a manufacturing site could be relocated to France, putting an investment in jeopardy.
First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map
Moderna shares are up almost 29% this month; CureVac is up 72% in the past month; and Novavax spiked 317% in the past month.
Healthcare Champions Kick Off 2024
Surprisingly, it is not Big Tech that kicked off 2024 but healtchare champions. Moderna Inc (NASDAQ: MRNA) shares rose after Oppenheimer upgraded the stock due to the Covid-19 vaccine star possibly marketing as many as five products by 2026. Merck & CO Inc (NYSE:
Contaminated Vaccines: FDA Reportedly Finds Cleaning And Expiry Lapses At Moderna's Massachusetts Facility
The U.S. Food and Drug Administration (FDA) identified several quality control issues at the primary manufacturing facility of Moderna Inc. (NASDAQ: MRNA) 
China's mRNA Pioneer Stemirna Faces Post-Covid Reinvention Test
Key Takeaways: Flush with funds from its backers, Stemirna built manufacturing plants that were able to produce up to 400 million vaccine doses a year and put together a sales force for an anticipated surge in Covid demand
Mainz Biomed To Present The Power Of mRNA That Promises To Revolutionize Medicine
Pharma companies across the globe, including Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA), are harnessing the potential of mRNA which is creating plenty of space for scientific improvement in the fight against pathogens.
More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone
New COVID-19 boosters have been approved by the U.S. FDA in the fight against new variants. A new survey showed how likely people are to get new boosters and if they will have their children get boosters.
Gavi's 6-In-1 Vaccine May Prove Game-Changer For Polio Eradication: STAT News
Zoetis Declares New Dividend, Hinting At Undervaluation
Zoetis (NYSE: ZTS) shareholders may have a new reference point to be excited about, even after witnessing some favorable developments through the company's first quarter 2023 announcements.
FDA Votes In Favor Of Pfizer's Maternal RSV Vaccine To Prevent Disease In Infants
The U.S.
Bill Gates Says Providing nOPV2-Like Vaccines To 'Zero-Dose' Children Will Usher In 'Healthier Future For Us All'
Bill Gates says we must immunize children who have not been vaccinated before to eradicate polio, a move that he says is essential to ensuring a "healthier future for us all."
NFL's Aaron Rodgers' Hail Mary For 2024 Presidential Election: Fellow Anti-Vaxxer Robert Kennedy Jr.
A leading National Football League player has shown early support for a presidential candidate ahead of the 2024 election. Here’s who quarterback Aaron Rodgers is supporting and how one important platform plays into the potential support. 
Jim Cramer Says He's Known Novavax Is 'Worthless' For 'Very Long Time,' Trashes Company For Being Too 'Promotional'
Novavax Inc (NASDAQ: NVAX) shares are crashing Wednesday after the company warned that substantial doubt exists regarding its ability to continue.  Jim Cramer isn't surprised.
EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch
Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information. For some, this is overwhelming.
US Stocks Show Cautious Optimism As S&P 500, Dow Futures Surge Ahead Of Key CPI Data — Trump's SPAC Partner, Applied Materials And Chip Stocks In Focus Today
The U.S. index futures are pointing to a higher opening on Wall Street, reflecting traders’ hopes that the consumer price inflation data may prove benign.
Former Disney Employees Sue Over Vaccine, Mask Rules
Three former Florida-based employees of the Walt Disney Co. (NYSE: DIS) have filed a lawsuit claiming that they were fired after challenging the company’s pandemic-era rules o
J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement
Johnson & Johnson (NYSE: JNJ) has made another move towards severing its Covid-19 vaccine manufacturing ties with contract manufacturer Emergent Biosolutions, Inc. (NYSE: EBS).
Pfizer To Boost Production Of Oral COVID-19 Pill With $120M Michigan Investment
Pfizer, Inc. (NYSE: PFE) is upping its commitment to manufacture its oral COVID-19 pill Paxlovid in the United States.
EXCLUSIVE: Tonix CEO Seth Lederman On The Pursuit Of New Monkeypox, COVID Vaccines
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a Chatham, New Jersey-based clinical-stage biopharmaceutical company, announced on Wednesday the issuance of a patent that forms the basis for the company's developmental vaccine against monkeypox and smallpox. 
Novavax's 22% Post-Earnings Plunge: 5 Factors That Took Toll
Novavax, Inc. (NASDAQ: NVAX) shares slumped 22.27% after-hours on Monday, reacting to its quarterly financial report.
;

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved